Replies to post #81795 on Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

I do not believe they'll officially announce shelving Aim2Cerv/AXAL programs. Their MO is to do it quietly, as they've done it before. Why would it be any different now?
Besides, the markets assign ZERO value to AXAL programs anyway. If anything gets done, it'll be an upside surprise.
I'm concerned by the lack of conference call and a failure to update on the status of the program which Ken promised three months ago. I'll take this silence as a sign of shutting down the platform.

[shub]

They had a potential fortune and real hope for saving thousands of lives from a horrible death in their hands.
Management urinated that away and allowed any possible IP protection to slowly expire.
This is my oldest holding and i've lost a great amount of money, having first bought at $14, pre-reverse split.
None of the promising "deals" have panned out.
The 2 remaining drug prospects are many years from fruition and the necessary clinical trials are far beyond the company's means.
I'm an utter idiot for not selling at $10 or $15 when i had the chance.
Management greed and ineptitude has cost us and myriad patients profoundly.